Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Elevance Health (ELV) has shared an announcement.
Elevance Health, Inc. is set to maintain optimistic communication with investors, affirming their net income guidance for the full year 2024 to exceed $34.05 per diluted share, despite some unfavorable items estimated at $3.15 per diluted share. Adjusted for these items, the net income is expected to surpass $37.20 per diluted share. This forecast is based on current projections and does not account for potential future adjustments. However, investors should be aware that these forward-looking statements are subject to various risks and uncertainties that could impact the company’s actual performance.
For a thorough assessment of ELV stock, go to TipRanks’ Stock Analysis page.